Supported by Charles River Laboratories
The Møller Centre | Cambridge
15-19 July 2019
Co-organised by the British Toxicology Society and the American College of Toxicology
REGISTRATION NOW OPEN
This highly acclaimed course will provide training in toxicology as applied in drug development to scientists from all parts of the World. Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with emphasis on the practical application of these principles and interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective. Through the week the students will participate in tutored group study of regulatory cases and original data from a regulatory submission which will conclude with a half-day workshop.
The course is intended to benefit individuals from biotechnology and pharmaceutical companies working with either small or large molecules, along with those from CROs, regulatory agencies and academia who are interested in toxicology and its application in safety assessment of drugs and medical products and for toxicologists early in their career seeking more in-depth knowledge and understanding of the role of toxicology in safety assessment. It is also suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) making a career change to work in drug safety assessment.
Applications for CPD credits will again be made to EUROTOX and the Royal Society of Biology.